Bioceres Crop Solutions Corp BIOX.OQ BIOX.O is expected to show a fall in quarterly revenue when it reports results on November 12 for the period ending September 30 2024
The Rosario Santa Fe-based company is expected to report a 6.3% decrease in revenue to $109.25 million from $116.6 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Bioceres Crop Solutions Corp is for a loss of 1 cent per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 2.4% in the last three months.
Wall Street's median 12-month price target for Bioceres Crop Solutions Corp is 13.00, above its last closing price of $6.57.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | 0.24 | -0.03 | Missed | -112.3 | |
Mar. 31 2024 | 0.17 | 0.17 | 0.14 | Missed | -17.6 |
Jan. 1 0001 | 0.08 | 0.09 | 0.02 | Missed | -79.3 |
Sep. 30 2023 | 0.06 | 0.06 | -0.07 | Missed | -221.7 |
Jan. 1 0001 | 0.00 | 0.05 | -0.06 | Missed | -230.4 |
Mar. 31 2023 | -0.03 | -0.03 | 0.44 | Beat | 1,792.3 |
Dec. 31 2022 | 0.01 | 0.07 | -307.4 | ||
Sep. 30 2022 | 0.04 | 0.05 | -83.3 |
This summary was machine generated November 8 at 15:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments